Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

(2018) Piet Geusens et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis

(2017) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

(2017) Felicia Cosman et al.   MAYO CLINIC PROCEEDINGS

Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

(2016) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

The effect of sequential therapy for postmenopausal women with osteoporosis

(2016) Shenghan Lou et al.   MEDICINE

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

(2016) Felicia Cosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Teriparatide for osteoporosis: importance of the full course

(2016) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

(2016) R. T. Burge et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporotic fractures and associated hospitalizations among patients treated with teriparatide compared to a matched cohort of patients not treated with teriparatide

(2015) Natalie Boytsov et al.   CURRENT MEDICAL RESEARCH AND OPINION

Real-world clinical and economic outcomes for daily teriparatide patients in Japan

(2015) Russel Burge et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study

(2015) D. P. Beall et al.   OSTEOPOROSIS INTERNATIONAL

Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)

(2014) Ö. Ljunggren et al.   CURRENT MEDICAL RESEARCH AND OPINION

Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches

(2014) Felicia Cosman   Current Osteoporosis Reports

Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study

(2013) Östen Ljunggren et al.   BMC MUSCULOSKELETAL DISORDERS

The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim report

(2013) Takanori Yamamoto et al.   JOURNAL OF BONE AND MINERAL METABOLISM

The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results

(2013) S. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review

(2012) S. Wilson et al.   OSTEOPOROSIS INTERNATIONAL

The impact of teriparatide adherence and persistence on fracture outcomes

(2011) S. Yu et al.   OSTEOPOROSIS INTERNATIONAL

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS

(2010) George Lyritis et al.   CURRENT MEDICAL RESEARCH AND OPINION

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

(2010) A. Fahrleitner-Pammer et al.   OSTEOPOROSIS INTERNATIONAL

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

The course of the acute vertebral body fragility fracture: its effect on pain, disability and quality of life during 12 months

(2008) Nobuyuki Suzuki et al.   EUROPEAN SPINE JOURNAL

Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*

(2008) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

(2008) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL